Imunon, Inc. Notes Payable, Noncurrent
Imunon, Inc. (IMNN) had Notes Payable, Noncurrent of $3.90 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2024-03-28
- 2023-03-31: Notes Payable, Noncurrent $3.90M.
- 2022-12-31: Notes Payable, Noncurrent $4.61M.
- 2022-09-30: Notes Payable, Noncurrent $5.32M.
- 2022-06-30: Notes Payable, Noncurrent $5.95M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2023-03-31 | $3.90M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.61M 10-K · filed 2024-03-28 |
| 2022-09-30 | $5.32M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.95M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.90M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.85M 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.81M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.76M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.25M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.93M 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.63M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $5.61M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $7.62M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $7.96M 10-K · filed 2021-03-19 |
| 2019-09-30 | $9.13M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.61M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.51M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $9.42M 10-K · filed 2020-03-25 |
| 2018-09-30 | $9.32M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $9.22M 10-Q · filed 2018-08-14 |
| 2016-03-31 | $1.32M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.35M 10-K · filed 2017-03-24 |
| 2015-09-30 | $3.34M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $4.29M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $5.19M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.05M 10-K · filed 2016-03-30 |
| 2014-09-30 | $6.89M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $7.87M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $4.56M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $5.00M 10-K · filed 2015-03-12 |
| 2013-09-30 | $2.35M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.85M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.17M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.66M 10-K · filed 2014-03-13 |
| 2012-09-30 | $4.14M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.61M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $57.14K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $71.60K 10-K · filed 2013-03-18 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-10 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 |
| 2010-12-31 | $56.40K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |